Table 1.
Properties of low- and high-amplitude IPSCs in control conditions in the presence of drugs as well as the difference between them
Amplitude, pA | Rise Time, ms | Decay Time, ms | Half Width, ms | |
---|---|---|---|---|
Control IPSCs | ||||
High | 167.2 ± 7.5* | 1.91 ± 0.15 | 17.3 ± 1.5 | 14.3 ± 1.0 |
Low | 92.3 ± 3.8* | 2.21 ± 0.13 | 20.6 ± 1.2 | 16.2 ± 0.9 |
Drug-resistant component | ||||
High | 120.0 ± 9.3* | 1.76 ± 0.16 | 13.7 ± 1.5 | 12.5 ± 0.9 |
Low | 54.7 ± 4.4* | 2.05 ± 0.18 | 15.5 ± 1.2 | 14.0 ± 0.8 |
Drug-sensitive component | ||||
High | 51.5 ± 5.2 | 2.64 ± 0.35 | 24.9 ± 3.7 | 19.7 ± 2.9 |
Low | 39.1 ± 3.6 | 2.32 ± 0.22 | 28.1 ± 1.9 | 20.1 ± 1.6 |
Values are means ± SE for control conditions in the presence of drugs (5-HT or CP93129; drug-resistant component) and the difference between them (drug-sensitive component); n = 14. In cells with low- and high-amplitude inhibitory postsynaptic currents (IPSCs), the 5-HT-sensitive component had a slower decay time than the 5-HT-resistant component (P < 0.001; see detailed statistics in main text). Whereas the amplitude of the 5-HT-sensitive current did not differ between the 2 subsets of cells, that of the 5-HT-resistant component was significantly higher in cells with high than low IPSC amplitudes (P < 0.001). CP93129 also shortened the decay time of GABAA IPSCs (P < 0.002).
P < 0.05, statistically significant differences between high vs. low.